Many people choose a time when they can rest if mild nausea occurs, typically choosing evenings at home rather than before a busy workday
That said, within the community of people that use BPC-157 for therapeutic reasons for tissue rejuvenation and repair, there's been an ongoing debate as to whether or not you can take it systemically
Of course I always try to find a juicy topic for member posts but what am I, magic
MACE-5 (all-cause death, MI, stroke, heart failure event, coronary revascularisation) 44 events on retatrutide, 52 on placebo: In-study: HR 0.82 (95% CI 0.551.22) On-treatment: HR 0.73 (95% CI 0.471.12) MACE-3 (CV death, MI, stroke) 27 events on retatrutide, 23 on placebo: In-study: HR 1.12 (95% CI 0.641.96) On-treatment: HR 0.92 (95% CI 0.511.65) Lilly states plainly that MACE occurred less frequently than anticipated in both arms
The mechanism behind this effect is not yet fully understood